Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis

PURPOSE: To evaluate fluorine 18 fluorodeoxyglucose (FDG) uptake in the thoracic aortic wall at combined positron emission tomography (PET)/computed tomography (CT) and compare uptake with aortic wall calcification.

MATERIALS AND METHODS: Records of 85 consecutive cancer patients who underwent FDG PET/CT were evaluated retrospectively. One hour after FDG injection, CT followed by PET was performed from ear to middle of the thigh. CT, PET, and fused PET/CT images were generated. FDG uptake and calcification were evaluated visually and semiquantitatively. FDG uptake was graded according to intensity; calcification, according to thickness. Unpaired t test was used for comparison of patient age with and without FDG uptake and with and without calcification. The relationship between the score (sum of grades along all aortic segments) of positive FDG uptake and calcification and patient age was analyzed with Spearman rank correlation. Comparison of frequency of FDG uptake and calcification with age, sex, risk factors for cardiovascular disease (CVD), or history of CVD was performed with χ2 analysis.

RESULTS: Fifty patients had at least one area of FDG uptake in thoracic aortic wall, 14 of whom showed focal FDG uptake. Intermediate to intense FDG uptake tended to be observed in the descending aorta. Forty-five patients had at least one measurable aortic calcification. Thick calcification was observed most often at the aortic arch. Twelve patients had 13 uptake areas at the calcification site. Patients with positive findings were on average older (P < .05 for both increased uptake and calcification); the older patient group had higher frequency of both aortic wall uptake (P < .005) and calcification (P < .001). The calcification score correlated with age (ρ = 0.60, P < .001) but the FDG uptake score did not. Women, patients with hyperlipidemia, and patients with history of CVD tended to show increased FDG uptake (P = .073, .080, and .068, respectively), whereas patients with diabetes had significantly more calcifications (P < .05).

CONCLUSION: PET/CT depicted FDG uptake commonly in the thoracic aortic wall. The FDG uptake site was mostly distinct from the calcification site and may possibly be located in areas of metabolic activity of atherosclerotic changes.

© RSNA, 2003

References

  • 1 Alexander RW, Dzau VJ. Vascular biology: the past 50 years. Circulation 2000; 102(suppl 4):IV112-IV116.
  • 2 Fuster V, Gotto AM, Jr. Risk reduction. Circulation 2000; 102(suppl 4):IV94-IV102.
  • 3 Lusis AJ. Atherosclerosis. Nature 2000; 407:233-241.
  • 4 Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
  • 5 Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001; 89:305-316.
  • 6 Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 2001; 221:285-299.
  • 7 Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 1999; 40:591-603.
  • 8 Coleman RE. PET in lung cancer. J Nucl Med 1999; 40:814-820.
  • 9 Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med 1999; 40:1706-1715.
  • 10 Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42:1S-93S.
  • 11 Lederman RJ, Raylman RR, Fisher SJ, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 2001; 22:747-753.
  • 12 Mochizuki Y, Fujii H, Yasuda S, et al. FDG accumulation in aortic walls. Clin Nucl Med 2001; 26:68-69.
  • 13 Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 2001; 26:314-319.
  • 14 Machac J, Zhang Z, Nunez R, Chen WT, Macapinlac HA, Larson SM. The relation of F-18 FDG uptake in human thoracic aortas and risk factors for CAD (abstr). J Nucl Med 2002; 43:190P.
  • 15 Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with 18F-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105:2708-2711.
  • 16 Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41:1369-1379.
  • 17 Bar-Shalom R, Keidar Z, Engel A, et al. A new combined dedicated PET/CT system in the evaluation of cancer patients (abstr). J Nucl Med 2001; 42:34P.
  • 18 Kamel EM, Goerres G, Dizendorf E, Burger C, von Schulthess GK. Image Fusion of whole-body FDG-PET and spinal CT in staging of bronchogenic carcinoma (abstr). J Nucl Med 2001; 42:35P.
  • 19 National Institutes of Health. Clinical guidelines on the identification evaluation and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6(suppl 2):51-209.
  • 20 Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-fluorine-18-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850.
  • 21 American Diabetic Association. A guide for professionals: the effective application of “exchange lists for meal planning.” Chicago, Ill: American Diabetic Association, 1977; 17.
  • 22 Vallabhajosula S, Machac J, Knesaurek K, et al. Imaging atherosclerotic lesions by positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG): preclinical studies in hypercholesterolemic rabbits (abstr). Circulation 1995; 92:313.
  • 23 Helft G, Worthley S, Zhang Z, et al. Non-invasive in vivo imaging of atherosclerotic lesions with fluorine-18 deoxyglucose 18-FDG PET correlates with macrophage content in a rabbit model (abstr). Circulation 1999; 18:I-311.
  • 24 Kiechl S, Willeit J. The natural course of atherosclerosis. I. Incidence and progression. Arterioscler Thromb Vasc Biol 1999; 19:1484-1490.
  • 25 Welty FK. Cardiovascular disease and dyslipidemia in women. Arch Intern Med 2001; 161:514-522.
  • 26 Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000; 283:2810-2815.
  • 27 Wilson PW, Kauppila LI, O’Donnell CJ, et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001; 103:1529-1534.
  • 28 Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89:763-771.
  • 29 Nakamoto Y, Osman M, Cohade C, et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med 2002; 43:1137-1143.

Article History

Published in print: Dec 2003